We must optimize stent deployment & maintain a registry of how well (or poorly) we use drug-eluting stents. Instead of asking “Which stent?” or “How much ...We must optimize stent deployment & maintain a registry of how well (or poorly) we use drug-eluting stents. Instead of asking “Which stent?” or “How much anti-platelet therapy?” we must ask “How effectively are we deploying our stents?”
to ultrasound stiffening MI DES ST-elevation endothelialization coronary angiogram techniques receptors deformation deployment clopidogrel drugs IVUS stents aspirin antiplatelet lesions thienopyridine quality intravascular direct restenosis occlusions BMS angioplasty apposition platelet polymerization infarction angiography compliant bare-metal drug-eluting non-compliant myocardial incomplete interventional johnson_&_johnson thrombogenicity thrombosis IIb/IIIa cardiologists abbott total balloons SIRIUS endpoints occlusion artery guidant vessel semi-compliant TAXUS deployed boston_scientifics ischemia unapposed stenting anti-platelet polymer vasculature methods cardiology directly-stented struts by avivagabriel on Jul 12, 2007, 4:51 AM